Cargando…
Validating Methylated HOXA9 in Bronchial Lavage as a Diagnostic Tool in Patients Suspected of Lung Cancer
SIMPLE SUMMARY: Diagnosing lung cancer requires invasive procedures with high risk of complications. Methylated tumor-specific DNA has been suggested as a biomarker for lung cancer. The present study aimed to develop and validate the biomarker methylated HOXA9 in fluid from the lung collected during...
Autores principales: | Wen, Sara W. C., Andersen, Rikke F., Rasmussen, Kristian, Thomsen, Caroline Brenner, Hansen, Torben Frøstrup, Nederby, Line, Hager, Henrik, Jakobsen, Anders, Hilberg, Ole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393370/ https://www.ncbi.nlm.nih.gov/pubmed/34439376 http://dx.doi.org/10.3390/cancers13164223 |
Ejemplares similares
-
NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
por: Wen, Sara Witting Christensen, et al.
Publicado: (2023) -
Cell Free Methylated Tumor DNA in Bronchial Lavage as an Additional Tool for Diagnosing Lung Cancer—A Systematic Review
por: Wen, Sara Witting Christensen, et al.
Publicado: (2022) -
Comparison of Mutated KRAS and Methylated HOXA9 Tumor-Specific DNA in Advanced Lung Adenocarcinoma
por: Wen, Sara W. C., et al.
Publicado: (2020) -
Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients
por: Borg, Morten, et al.
Publicado: (2022) -
The prognostic impact of circulating homeobox A9 methylated DNA in advanced non-small cell lung cancer
por: Wen, Sara Witting Christensen, et al.
Publicado: (2021)